2006 Legislation
Print Friendly

HOUSE BILL NO. 617 – Carisoprodol, controlled substance

HOUSE BILL NO. 617

View Bill Status

View Bill Text

View Statement of Purpose / Fiscal Impact



Text to be added within a bill has been marked with Bold and
Underline. Text to be removed has been marked with
Strikethrough and Italic. How these codes are actually displayed will
vary based on the browser software you are using.

This sentence is marked with bold and underline to show added text.

This sentence is marked with strikethrough and italic, indicating
text to be removed.

Bill Status



H0617.................................................by HEALTH AND WELFARE
CARISOPRODOL - Amends existing law to add carisoprodol to Schedule IV of
the Idaho controlled substance schedules.
                                                                        
02/09    House intro - 1st rdg - to printing
02/10    Rpt prt - to Health/Wel
03/09    Rpt out - rec d/p - to 2nd rdg
03/10    2nd rdg - to 3rd rdg
03/14    3rd rdg - PASSED - 37-31-2
      AYES -- Andrus, Barraclough, Bastian, Bell, Bilbao, Block, Boe, Bolz,
      Cannon, Chadderdon, Deal, Field(18), Field(23), Garrett, Henbest,
      Henderson, Jaquet, Kemp, LeFavour, Martinez, Mitchell, Pasley-Stuart,
      Pence, Ring, Ringo, Rusche, Sayler, Shepherd(2), Shirley, Smith(30),
      Smith(24), Smylie, Snodgrass, Stevenson, Trail, Wills, Mr. Speaker
      NAYS -- Anderson, Barrett, Bayer, Bedke, Brackett, Bradford, Clark,
      Collins, Denney, Edmunson, Ellsworth, Eskridge, Hart, Harwood, Lake,
      Loertscher, Mathews, McGeachin, McKague, Miller, Moyle, Nielsen,
      Nonini, Raybould, Roberts, Rydalch, Sali, Schaefer, Shepherd(8),
      Skippen, Wood
      Absent and excused -- Black, Crow
    Floor Sponsor - Ring
    Title apvd - to Senate
03/14    Senate intro - 1st rdg - to Health/Wel

Bill Text


                                                                        
                                                                        
  ]]]]              LEGISLATURE OF THE STATE OF IDAHO             ]]]]
 Fifty-eighth Legislature                   Second Regular Session - 2006
                                                                        
                                                                        
                              IN THE HOUSE OF REPRESENTATIVES
                                                                        
                                     HOUSE BILL NO. 617
                                                                        
                              BY HEALTH AND WELFARE COMMITTEE
                                                                        
  1                                        AN ACT
  2    RELATING TO CONTROLLED SUBSTANCES; AMENDING SECTION 37-2711,  IDAHO  CODE,  TO
  3        ADD CARISOPRODOL TO SCHEDULE IV OF IDAHO CONTROLLED SUBSTANCE SCHEDULES.
                                                                        
  4    Be It Enacted by the Legislature of the State of Idaho:
                                                                        
  5        SECTION  1.  That  Section 37-2711, Idaho Code, be, and the same is hereby
  6    amended to read as follows:
                                                                        
  7        37-2711.  SCHEDULE IV. (a) Schedule IV shall  consist  of  the  drugs  and
  8    other  substances,  by  whatever official name, common or usual name, chemical
  9    name, or brand name designated, listed in this section.
 10        (b)  Narcotic drugs. Unless specifically  excepted  or  unless  listed  in
 11    another  schedule,  any material, compound, mixture, or preparation containing
 12    any of the following narcotic drugs, or their salts  calculated  as  the  free
 13    anhydrous base or alkaloid, in limited quantities as set forth below:
 14        (1)  No more than 1 milligram of difenoxin and not less than 25 micrograms
 15        of atropine sulfate per dosage unit;
 16        (2)  Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,
 17        2-diphenyl-3-methyl-2-propionoxybutane).
 18        (c)  Depressants. Unless specifically excepted or unless listed in another
 19    schedule,  any  material, compound, mixture, or preparation which contains any
 20    quantity of the following substances, including its salts, isomers, and  salts
 21    of isomers whenever the existence of such salts, isomers, and salts of isomers
 22    is possible within the specific chemical designation:
 23        (1)  Alprazolam;
 24        (2)  Barbital;
 25        (3)  Bromazepam;
 26        (4)  Camazepam;
 27        (5)  Chloral betaine;
 28        (6)  Chloral hydrate;
 29        (7)  Chlordiazepoxide;
 30        (8)  Clobazam;
 31        (9)  Clonazepam;
 32        (10) Clorazepate;
 33        (11) Clotiazepam;
 34        (12) Cloxazolam;
 35        (13) Delorazepam;
 36        (14) Diazepam;
 37        (15) Estazolam;
 38        (16) Ethchlorvynol;
 39        (17) Ethinamate;
 40        (18) Ethyl loflazepate;
 41        (19) Fludiazepam;
 42        (20) Flurazepam;
 43        (21) Halazepam;
                                                                        
                                           2
                                                                        
  1        (22) Haloxazolam;
  2        (23) Ketazolam;
  3        (24) Loprazolam;
  4        (25) Lorazepam;
  5        (26) Lormetazepam;
  6        (27) Mebutamate;
  7        (28) Medazepam;
  8        (29) Meprobamate;
  9        (30) Methohexital;
 10        (31) Methylphenobarbital (mephobarbital);
 11        (32) Midazolam;
 12        (33) Nimetazepam;
 13        (34) Nitrazepam;
 14        (35) Nordiazepam;
 15        (36) Oxazepam;
 16        (37) Oxazolam;
 17        (38) Paraldehyde;
 18        (39) Petrichloral;
 19        (40) Phenobarbital;
 20        (41) Pinazepam;
 21        (42) Prazepam;
 22        (43) Temazepam;
 23        (44) Tetrazepam;
 24        (45) Triazolam;
 25        (46) Quazepam;
 26        (47) Zolpidem.
 27        (d)  Fenfluramine  - Any material, compound, mixture, or preparation which
 28    contains any quantity  of  the  following  substances,  including  its  salts,
 29    isomers  (whether optical, position, or geometric), and salts of such isomers,
 30    whenever the existence of such salts, isomers, and salts of isomers is  possi-
 31    ble:
 32        (1)  Fenfluramine.
 33        (e)  Stimulants.  Unless specifically excepted or unless listed in another
 34    schedule, any material, compound, mixture, or preparation which  contains  any
 35    quantity  of the following substances having a stimulant effect on the central
 36    nervous system, including its salts, isomers (whether  optical,  position,  or
 37    geometric),  and  salts  of such isomers whenever the existence of such salts,
 38    isomers, and salts of isomers is possible within the specific chemical  desig-
 39    nation:
 40        (1)  Cathine ((+)-norpseudoephedrine);
 41        (2)  Diethylpropion;
 42        (3)  Fencamfamin;
 43        (4)  Fenproporex;
 44        (5)  Mazindol;
 45        (6)  Mefenorex;
 46        (7)  Pemoline (including organometallic complexes and chelates thereof);
 47        (8)  Phentermine;
 48        (9)  Pipradrol;
 49        (10) Sibutramine;
 50        (11) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
 51        (f)  Other  substances.  Unless specifically excepted, or unless listed in
 52    another schedule, any material, compound, mixture or  preparation  which  con-
 53    tains any quantity of the following substance, including its salts:
 54        (1)  Carisoprodol;
 55        (2)  Pentazocine.
                                                                        
                                           3
                                                                        
  1        (g)  The  board  may  except by rule any compound, mixture, or preparation
  2    containing any depressant substance listed in subsection (c) of  this  section
  3    from  the application of all or any part of this act if the compound, mixture,
  4    or preparation contains one (1) or more active medicinal ingredients not  hav-
  5    ing  a  depressant effect on the central nervous system, and if the admixtures
  6    are included therein in combinations, quantity, proportion,  or  concentration
  7    that vitiate the potential for abuse of the substances which have a depressant
  8    effect on the central nervous system.

Statement of Purpose / Fiscal Impact



                       STATEMENT OF PURPOSE

                             RS 15421

     The purpose of this legislation is to place carisoprodol on
the Class IV drug list.  
                                 



                          FISCAL NOTE

     There is no cost to the General Fund.






Contact
Name:     Representative Ring 
Phone:    332-1000

STATEMENT OF PURPOSE/FISCAL NOTE                       H 617